Canada markets close in 36 minutes

Exor N.V. (EXXRF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
111.310.00 (0.00%)
As of 01:20PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close111.31
Open111.31
Bid0.00 x 0
Ask0.00 x 0
Day's Range111.31 - 111.31
52 Week Range80.84 - 112.70
Volume53
Avg. Volume971
Market Cap24.013B
Beta (5Y Monthly)N/A
PE Ratio (TTM)5.65
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.49 (0.44%)
Ex-Dividend DateMay 30, 2024
1y Target EstN/A
  • Reuters

    Agnellis' Exor targets growth in healthcare sector

    Exor, the investment arm of the Agnelli family, has a growing interest in the healthcare industry, where it has already invested almost 4 billion euros ($4.3 billion), CEO John Elkann said on Thursday. "The increased cost of healthcare services combined with a shortage of medical staff is driving demand for innovative new approaches to tackle global health problems," he said in his annual letter to Exor shareholders. Exor views healthcare as a "long-term, structural growth sector," added Elkann, the scion of the Agnelli family and chair of automakers Stellantis and Ferrari.

  • Reuters

    UPDATE 1-Agnellis' Exor targets growth in healthcare sector

    Exor, the investment arm of the Agnelli family, has a growing interest in the healthcare industry, where it has already invested almost 4 billion euros ($4.3 billion), CEO John Elkann said on Thursday. "The increased cost of healthcare services combined with a shortage of medical staff is driving demand for innovative new approaches to tackle global health problems," he said in his annual letter to Exor shareholders. Exor views healthcare as a "long-term, structural growth sector," added Elkann, the scion of the Agnelli family and chair of automakers Stellantis and Ferrari.

  • Reuters

    Exor has growing interest in healthcare industry

    Exor, the investment arm of the Agnelli family, has a growing interest in the healthcare industry, where it has already invested almost 4 billion euros ($4.3 billion), CEO John Elkann said on Thursday. "The increased cost of healthcare services combined with a shortage of medical staff is driving demand for innovative new approaches to tackle global health problems," he said in his annual letter to Exor shareholders. Exor views healthcare as a "long-term, structural growth sector," said Elkann, the scion of the Agnelli family and chair of automakers Stellantis and Ferrari.